Okami Medical Completes $32.5 Million Venture Funding

Represented Okami Medical in securing $32.5 million in venture funding in a deal led by Vensana Capital. U.S. Venture Partners and other undisclosed investors also participated in the round. Okami is a developer of a peripheral embolization device designed to treat cardiovascular disease for the occlusion of peripheral vessels. This funding, which included $5.735 million converted from convertible debt to equity, will support Okami’s mission to advance and commercialize its innovative catheter-based technologies for peripheral vascular occlusion. We also advised Okami on its Series C, D and E venture financings. To date, Okami has raised $56.35 million.